type here...

activists

What Happens When Multinationals Appear in Reporting on Activist Assassinations? High-Profile Media Has Bite

A new report finds that being linked to human rights abuses—merely appearing in reporting around high-profile events—can significantly influence a company’s stock...
Read more

Barking Up the Right Tree: How Shareholder Activists Raise Issues to Placate Large Mutual Funds

A new paper examines whether shareholder activists tailor their campaigns to persuade large institutional investors and finds that in proxy communications, activists...
Read more

How to Lobby on E-Waste? A New Stigler Center Case Study on the Hewlett-Packard Dilemma

Brian K. Richter’s case study illustrates how firms can use lobbying strategies to complement socially responsible activities that are cost centers and turn them...
Read more

LATEST NEWS

Coronavirus

Female Academics Are Disproportionately Affected By Covid-19 Disruptions In Childcare

Tatyana Deryugina, Olga Shurchkov, Jenna Stearns
A new paper finds that academics who are parents to young children, and especially mothers, have lost a significant amount of research...
Read more
Antitrust and Competition

Rethinking Competition: From Market Failures to Ecosystem Failures

Michael G Jacobides, Ioannis Lianos
Despite the overwhelming importance of digital platforms, and the chatter around their recent rise, our understanding of digital ecosystems is still limited....
Read more
Corporate Governance

A Famed Economist’s Public Company U-Turn

Brian Cheffins
Michael Jensen, a leading late 20th century economist, pivoted from praising public companies in the 1970s to assailing public company governance in...
Read more
Antitrust and Competition

Chinese Antitrust 2.0: Why Is China Going After Its Big Tech?

Jana Kasperkevic
In an interview with ProMarket, Angela Huyue Zhang, author of a new book Chinese Antitrust Exceptionalism, discusses the motivations behind the recent...
Read more
Antitrust and Competition

Preventing Drug Shortages and Saving Lives: The Role of Quality and Reliability Standards

Rena Conti, Fiona Scott Morton, Adam Kroetsch, Stephen Colvill, Mark Rosenberg
Prescription drug shortages have become more common in recent years, interrupting usual medical care and increasing patient risk and system costs, but...
Read more

ProMarket is dedicated to discussing how competition tends to be subverted by special interests. The posts represent the opinions of their writers, not necessarily those of the University of Chicago, the Booth School of Business, or its faculty. For more information, please visit ProMarket Policy.

About Us

Categories

What we are readingAntitrust and CompetitionNewsRegulatory CaptureMediaRent seeking